E-resources
Peer reviewed
Open access
-
Chen, Pei; Lin, Juei-Jueng; Lu, Chin-Song; Ong, Cheung-Ter; Hsieh, Peiyuan F; Yang, Chih-Chao; Tai, Chih-Ta; Wu, Shey-Lin; Lu, Cheng-Hsien; Hsu, Yung-Chu; Yu, Hsiang-Yu; Ro, Long-Sun; Lu, Chung-Ta; Chu, Chun-Che; Tsai, Jing-Jane; Su, Yu-Hsiang; Lan, Sheng-Hsing; Sung, Sheng-Feng; Lin, Shu-Yi; Chuang, Hui-Ping; Huang, Li-Chen; Chen, Ying-Ju; Tsai, Pei-Joung; Liao, Hung-Ting; Lin, Yu-Hsuan; Chen, Chien-Hsiun; Chung, Wen-Hung; Hung, Shuen-Iu; Wu, Jer-Yuarn; Chang, Chi-Feng; Chen, Luke; Chen, Yuan-Tsong; Shen, Chen-Yang
The New England journal of medicine, 03/2011, Volume: 364, Issue: 12Journal Article
Carbamazepine, an anticonvulsant and a mood-stabilizing drug, is the main cause of the Stevens-Johnson syndrome (SJS) and its related disease, toxic epidermal necrolysis (TEN), in Southeast Asian countries. Carbamazepine-induced SJS-TEN is strongly associated with the HLA-B*1502 allele. We sought to prevent carbamazepine-induced SJS-TEN by using HLA-B*1502 screening to prospectively identify subjects at genetic risk for the condition. From 23 hospitals in Taiwan, we recruited 4877 candidate subjects who had not taken carbamazepine. We genotyped DNA purified from the subjects' peripheral blood to determine whether they carried the HLA-B*1502 allele. Those testing positive for HLA-B*1502 (7.7% of the total) were advised not to take carbamazepine and were given an alternative medication or advised to continue taking their prestudy medication; those testing negative (92.3%) were advised to take carbamazepine. We interviewed the subjects by telephone once a week for 2 months to monitor them for symptoms. We used the estimated historical incidence of SJS-TEN as a control. Mild, transient rash developed in 4.3% of subjects; more widespread rash developed in 0.1% of subjects, who were hospitalized. SJS-TEN did not develop in any of the HLA-B*1502-negative subjects receiving carbamazepine. In contrast, the estimated historical incidence of carbamazepine-induced SJS-TEN (0.23%) would translate into approximately 10 cases among study subjects (P<0.001). The identification of subjects carrying the HLA-B*1502 allele and the avoidance of carbamazepine therapy in these subjects was strongly associated with a decrease in the incidence of carbamazepine-induced SJS-TEN. (Funded by the National Science Council of Taiwan and the Taiwan Drug Relief Foundation.).
Author
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.